Barzilai N, Massillon D, Rossetti L
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Biochem J. 1995 Sep 15;310 ( Pt 3)(Pt 3):819-26. doi: 10.1042/bj3100819.
Experimental diabetes and fasting are both associated with hypoinsulinaemia and share several other metabolic features. We investigated hepatic and peripheral glucose metabolism in young rats after near-total depletion of their fat mass. Conscious rats were fasted for 72 h (n = 13), while 6 h-fasted animals (n = 14) served as controls. Rats were studied either during saline infusion or insulin (18 m-units/kg per min)-clamp studies. In fasting, despite a 2-fold increase in hepatic glucose-6-phosphatase (Glc-6-Pase) Vmax. (from 16 +/- 2 mumol/g of liver per min in control; P < 0.001), the basal hepatic glucose production (HGP) decreased by 47% [from 88 +/- 3 mumol/kg lean body mass (LBM) per min in control; P < 0.01]. The decreased HGP in fasting was associated with a 70% decrease in the hepatic levels of glucose 6-phosphate (Glc-6-P) (from 366 +/- 53 nmol/g wet wt. in control; P < 0.01). Thus Glc-6-Pase activity assayed in the presence of the Glc-6-P levels found in vivo was decreased by 44%. During hyperinsulinaemia, peripheral glucose uptake was decreased by 15% with 3 days of fasting (from 272 +/- 17 mumol/kg LBM per min in control; P < 0.01). This was completely accounted for by a 42% decrease in whole-body glycolysis (P < 0.01), while the rate of glycogen synthesis was unchanged. Thus fasting (after near-total fat depletion) differs from experimental diabetes because: (1) despite markedly increased Glc-6-Pase, HGP is decreased in fasting, due to a marked decrease in the substrate level (Glc-6-P) in vivo; and (2) the impairment in peripheral insulin sensitivity in fasting is due to a decrease in the glycolytic, and not the glycogen-synthetic, pathway.
实验性糖尿病和禁食均与低胰岛素血症相关,且具有其他一些共同的代谢特征。我们研究了年轻大鼠脂肪量几乎完全耗尽后的肝脏和外周葡萄糖代谢情况。清醒大鼠禁食72小时(n = 13),而禁食6小时的动物(n = 14)作为对照。在生理盐水输注期间或胰岛素(18 m单位/千克每分钟)钳夹研究期间对大鼠进行研究。在禁食状态下,尽管肝脏葡萄糖-6-磷酸酶(Glc-6-Pase)的最大反应速度(Vmax)增加了2倍(从对照时的16±2微摩尔/克肝脏每分钟增加;P < 0.001),但基础肝脏葡萄糖生成(HGP)却下降了47%[从对照时的88±3微摩尔/千克瘦体重(LBM)每分钟下降;P < 0.01]。禁食时HGP的下降与肝脏中葡萄糖6-磷酸(Glc-6-P)水平下降70%相关(从对照时的366±53纳摩尔/克湿重下降;P < 0.01)。因此,在体内发现的Glc-6-P水平存在时测定的Glc-6-Pase活性下降了44%。在高胰岛素血症期间,禁食3天时外周葡萄糖摄取下降了15%(从对照时的272±17微摩尔/千克LBM每分钟下降;P < 0.01)。这完全是由于全身糖酵解下降了42%(P < 0.01),而糖原合成速率未变。因此,禁食(在脂肪几乎完全耗尽后)与实验性糖尿病不同,原因如下:(1)尽管Glc-6-Pase明显增加,但禁食时HGP下降,这是由于体内底物水平(Glc-6-P)明显下降;(2)禁食时外周胰岛素敏感性受损是由于糖酵解途径下降,而非糖原合成途径下降。